ArticleJournal of clinical microbiology2013
Clostridium difficile ribotype diversity at six health care institutions in the United States.
Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin.The Journal of antimicrobial chemotherapy · 2018Trial
- Phenotypic analysis of variousApplied and environmental microbiology · 2025Article
- Phenotypic analysis of variousbioRxiv : the preprint server for biology · 2025Article
- Sentinel surveillance and epidemiology ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022Article
- Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.PLoS pathogens · 2021Article
- Retrospective Definition ofDiagnostics (Basel, Switzerland) · 2020Article
- Homologous Recombination inmSphere · 2020Article
- Clostridioides difficile infection in US hospitals: a national inpatient sample study.International journal of colorectal disease · 2020Article
- Biological characteristics associated with virulence inEmerging microbes & infections · 2020Article
- Enterotoxic Clostridia:Microbiology spectrum · 2019Review
- Proteotyping ofFrontiers in microbiology · 2019Article
- Review
- Review
- Control ofMicrobiology spectrum · 2017Review
- Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.PloS one · 2017Article
- Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.The journals of gerontology. Series A, Biological sciences and medical sciences · 2016Review
- Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Nature reviews. Gastroenterology & hepatology · 2016Review
- Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease.BMC microbiology · 2016Article
- An Update on Clostridium difficile Toxinotyping.Journal of clinical microbiology · 2016Review
- U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.Antimicrobial agents and chemotherapy · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Capillary-based PCR ribotyping was used to quantify the presence/absence and relative abundance of 98 Clostridium difficile ribotypes from clinical cases of disease at health care institutions in six states of the United States. Regionally important ribotypes were identified, and institutions in close proximity did not necessarily share more ribotype diversity than institutions that were farther apart.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.